SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AEROB) today announced the filing with the District Court of Dusseldorf of a Complaint and Motion to prevent Medisoft, P.A.E from marketing and selling its exhaled Nitric Oxide (NO) analyser in Germany. The claim seeks both an injunction and damages.
